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Targeted temperature management (TTM) is the recommended therapy for comatose patients 
after an out-of-hospital cardiac arrest resuscitation due to the reduction in neurological damage 
and improved outcomes. However, there may result in electrocardiographic instability 
depending on the degree of TTM, including minor or life threatening dysrhythmias or 
conduction delays. Thus, this project aims to describe the frequency of ECG interval changes and 
clinically relevant dysrhythmias in TTM patients.  
Methods 
This is a retrospective observational study from January 2009 to December 2015. Patients who 
qualified for the study had a non-traumatic cardiac arrest with a return of spontaneous 
circulation (ROSC), received TTM at 33.5oC for 24 hours followed by 16 hours of rewarming. 
ECG interval changes and dysrhythmias were recorded immediately after ROSC, and at 24 and 
48 hours post ROSC.  
Results 
A total of 322 patients (age 61.0 ± 16.9 years) had TTM initiated during the study period, of 
which 169 had complete data and 13 died prior to completing 24 hours of hypothermia. There 
were statistically significant changes during TTM in heart rate (96.7 ± 26.0/min before TTM; 
69.5 ± 19.1/min during, p<0.001); QRS duration (115.1 ± 32.6 ms before TTM; 107.8 ± 27.9 ms 
during TTM, p<0.001); and QTc (486.3 ± 52.8 ms before TTM; 526.9 ± 61.7 ms during TTM, 
p<0.001). There were cardiac dysrhythmias that received treatment during cooling and 
rewarming.  
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Conclusion 
During the period of TTM and rewarming, we observed few self-limiting ECG interval changes 





It is estimated that there are approximately 395,000 cases of out-of-hospital cardiac 
arrest (OHCA) per year in the U.S. with survival to discharge ranging from 3.0% to 39.9% based 
on geographical region.1,2 Patients resuscitated post cardiac arrest are at increased risk of 
developing further myocardial abnormalities e.g. post-cardiac arrest syndrome, along with 
systemic and brain injuries.  Targeted temperature management (TTM) has shown to improve 
neurological function and outcomes thought to be due to a reduction in the body’s oxygen 
demand and reperfusion injury associated damage.3,4 Thus, TTM is recommended by the 
American Heart Association Guidelines for Cardiopulmonary Resuscitation and is standard care 
in adults who remain comatose after an OHCA with ROSC around the world.5,6 
Accidental hypothermia studies have shown that hypothermia itself can cause adverse 
cardiac events, such as bradycardia, Osborn waves, atrial fibrillation, and QTc prolongation, 
predisposing patients to life-threatening ventricular arrhythmias.7 These arrhythmias are 
hypothesized to be due to serum electrolyte changes, including an increase intracellular 
calcium, combined myocardial repolarization variability that occurs with hypothermia.8 
Multiple case reports and studies demonstrate that hypothermia is associated with a significant 
prolongation in QT and QTc interval.9,10 
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Importance 
With the conduction delays and cardiac arrhythmias noted with hypothermia, concern is 
raised about the effect of TTM on the cardiac electrophysiology, specifically when there are no 
current guidelines for monitoring or assessing risk of arrhythmias, possibly deterring 
physicians from inducing TTM.  
Although TTM is standard in treating comatose, post-cardiac arrest patients after ROSC, 
there are few large studies that have studied the incidence of arrhythmias and conduction 
delays during treatment.11-15  
Goals of This Investigation 
The purpose of this study was to determine the frequency of clinically relevant ECG 
changes and cardiac dysrhythmias in a large population undergoing TTM.  
 
Materials and Methods 
Study Design and Setting 
We conducted a retrospective observational study of ECGs from adult patients (> 18 
years) who received TTM (33.5 oC for 24 hours) and who had return of spontaneous circulation 
(ROSC) after non-traumatic cardiac arrest at two large academic community hospitals from 
January 2009 to December 2015.  Both institutions provided targeted temperature management 
during the study period for comatose post arrest patients.  Patients are cooled using either 
external or endovascular cooling devices, with the vast majority being surface cooling(Artic Sun, 
Medivance, Inc, Louisville,Co)  to a target temperature of 33.5 oC, kept at that temperature for 24 
hours, and then gradually rewarmed to a temperature of 37.0 C over the subsequent 16 hours. 
Normothermia was maintained thereafter. Metabolic, ventilation, and hemodynamic 
parameters were managed according to goal directed targets for the first 72 hours in 
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consultation with critical care unit staff. Bolus paralytics or continuous drips were dosed for 
patients to control shivering.  
Measurements  
We reviewed ECGs obtained immediately upon hospital arrival post ROSC, as well as 24 
hours and 48 hours post ROSC. ECGs were abstracted for presence of dysrhythmia at these time 
points.  ECG intervals using computerized measures including PR, QRS and QT intervals as well 
as ST segment changes were abstracted. Charts were also reviewed for presence of cardiac 
dysrhythmias that were new in onset and occurred during cooling and rewarming as well as 
clinically significant dysrhythmias included ventricular tachycardia and ventricular fibrillation. 
A single observer reviewed records for data extraction and then two independent observers 
reviewed a sample of the data extraction and discrepancies were resolved by consensus.  
Analysis 
Descriptive statistics are reported for frequency of adverse events. Continuous variables 
including age (years), initial temperature (degrees Celsius), and all time intervals (milliseconds, 
minutes or hours) are reported as means and standard deviations (SDs); categorical variables 
are reported as counts and percentages. 
Data were analyzed using IBM SPSS (V19.0, Armonk NY) software, with a significance 
level of alpha = 0.05. Intervals were compared between pre-cooling, cooling and post cooling 
time periods and paired T-tests were calculated for associations. Beaumont Health System 
institutional review board approved the study.  
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Results 
Characteristics of Study Subjects 
During the study period, a total of 322 patients (age 61.0 ± 16.9 years) received TTM, of 
which 13 died prior to completion of treatment. Of the 13 that died, 9 died during rewarming – 
1 had PEA, 1 asystole, 1 code status changed to DNR, and 6 terminally weaned. Four died during 
TTM - 2 terminally weaned, 1 code status changed to DNR and 1 had PEA.  The deaths from PEA 
and asystole were primarily related to persistent hypotension and one had DIC. 
ECGs were performed as directed by the clinical team and were not recovered for 
patients prior to cooling (N=11), during cooling (N=65), and after cooling (N=32). Seven 
patients had paced rhythms and were excluded from analysis. (Figure 1). Demographic 
characteristics of the population are summarized in Table 1. The patients were predominately 
male (62.5%), 76% had an out-of-hospital arrest, 16.1% had a STEMI on initial ECG, and 35.7% 
survived to hospital discharge.  Most patients were normothermic prior to initiation of TTM, 
core temperature median 36.1 (IQR, 35.4, 36.7) 
Main Results 
Few patients developed significant dysrhythmias during and after, summarized in table 
2. During cooling, there was no recorded development of ventricular tachycardia (VT) or 
ventricular fibrillation (VF), 3 developed atrial fibrillation, 1 developed atrial flutter, and 6 AV 
nodal rhythms. These dysrhythmias during cooling resolved spontaneously without treatment. 
Osborn waves were common occurring in 23 patients during treatment After TTM, no recorded 
developments of VT or VF, but 7 developed atrial fibrillation, 1 developed atrial flutter, 4 
developed AV nodal rhythms, and Osborn waves were present in 5 patients.  
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There were statistically significant changes during TTM compared to prior with a 
decreased heart rate, and lengthened QRS duration  and QTc (Table 3). There were also 
statistically significant changes after TTM compared to during TTM with an increased heart 
rate, and shortened QRS and QTc. (Table 4).  Most intervals returned to normal after return to 
normothermia (Figures 2-5).  
Limitations:  
There are multiple limitations of this study: the first is that it is a retrospective chart 
review with no control group. This could allow for confounding variables, i.e. electrolyte 
imbalances and medications that were not reviewed by study authors but monitored and 
treated by clinical providers. These are  known to affect ECG intervals and cause arrhythmias. 
The second is that 47.5% (N=153) of the patients who underwent TTM did not have complete 
ECG data due to missing ECGs, or died before treatment was completed, thus excluded from 
analysis (see Figure 1).  We believe that reasons for missing data were random, as we cannot 
hypothesize any systemic reason for ECGs being absent.  Given that our preferred cooling 
mechanism is a surface device with large pads, it seems likely that this was a perceived, if not 
real barrier to obtaining an ECG.    The data was also analyzed based on single ECGs in each time 
period, so there may be transient arrhythmias not captured on ECG.  
 
Discussion: 
Congruent with prior studies, we showed a statistically significant decrease in heart rate 
with a statistically significant increase in QT and QTc interval during TTM primarily using 
surface cooling, that spontaneously resolved when rewarmed. The bradycardia and prolonged 
QT interval is thought to be due to the slowing rate of diastolic depolarization in both the 
sinoatrial nodal and myocardial cells as temperature decreases. This prolongs the electrical 
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conduction between myocardial cells, increasing the action potential duration causing 
prolongation of electrocardiographic intervals, including QT, as seen in our population.15,16   
Prolonged QT/QTc interval has been associated with clinically significant cardiac 
dysrhythmias, i.e. Torsades de Pointes, VT and VF, as observed in congenital diseases, 
hypokalemia, medications, severe accidental hypothermic individuals, etc.13 Although not 
analyzed in our study, prior literature has shown that electrolyte disturbances and medications 
are known to prolong ECG intervals in non-hypothermic states. Rosol, et al. mentioned that 
there was no difference in QTc intervals in patients with electrolyte imbalances and/or QT-
prolonging medications compared to those without in their study. There was also not a 
significant difference in those who developed arrhythmias.9 Thus, QT and QTc prolongation 
observed in our study and the lack of clinically significant dysrhythmias with hypothermia, is 
likely similar to other studies in that they are not affected by electrolyte imbalances and QT 
prolonging medications. 
To our knowledge, the current study is the one of the largest studies examining the 
relationship between QT, QTc and arrhythmias during TTM. Literature on TTM has shown that 
the QTc prolongation during treatment is not associated with significant cardiac dysrhythmias. 
Gachoka, et al. reported none of 55 patients undergoing TTM developed Torsades de pointes or 
ventricular tachycardia.15 Ulmenstein, et al. reported 13.7% of 95 patients had VT and VF, and 
Rosol, et al., the largest reported study to date, reported 11.3% of 193 patients developed a VT, 
VF or Torsades de pointes. Both latter studies showed no statistical difference in QT or QTc 
interval between those with and without ventricular arrhythmias.8,9 
In comparison to our study, of the few patients who developed dysrhythmias, none were 
clinically significant (Table 2). Potentially as incongruent with other studies, we did not use 
continuous telemetry monitoring to determine if a clinically significant, albeit transient, 
dysrhythmias were present.9,12,15 It is presumed though if a patient had even a transient 
arrhythmia that it would be documented on the chart. Regardless, our study found no clinically 
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significant dysrhythmias despite significant QTc prolongation during hypothermia, unlike other 
large studies.  
 It is thought that unlike temperatures less than 30°C, at mild hypothermic ranges (32-
35°C) there is a cardioprotective effect from membrane stabilization, and decrease in metabolic 
waste and reactive oxygen species that protects against prolonged QTc interval arrhythmias.15 
This is important as TTM has become standard care in post-cardiac arrest patients who are 
already at an increased risk of arrhythmias and data is needed to identify if more stringent 
monitoring guidelines are needed.  
It is also worth noting that we noted the QRS to significantly shorten from prior to TTM 
to during TTM to normothermia. This was similarly first described in Lebeidz, et al. who noted 
that the QRS interval decreased throughout the treatment, similar to our data.11 In other studies, 
the QRS interval is noted to significantly decrease from hypothermia to after cessation of 
treatment. However it is not noted to be associated with arrhythmias, and likely to be a benign 
finding.8,12    
Future studies should include prospective evaluations with recording of electrolytes and 
medications to control for other sources of QTc prolongation. Optimally continuous telemetry 
recordings before, during and after TTM should be used to capture transient arrhythmias that 
self-resolve. 
In this study, TTM is associated with a number of statistically significant ECG interval 
changes, i.e. decrease in heart rate and QRS, and increase in QTc interval that spontaneously 
resolved during rewarming, congruent with other studies. Despite the transient ECG interval 
changes, we observed no clinically significant arrhythmias defined as VT and VF, indicating that 
TTM is a low risk treatment in post-cardiac arrest patients irrespective of their pre-TTM QTc.  
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Description of how patients were excluded from the total number of populations who 
underwent targeted temperature management to the population in which data was analyzed. 
Targeted temperature management = TTM, Return of spontaneous circulation = ROSC
Patients (≥  18 y.o.) had non-traumatic cardiac 
arrest with ROSC from January 2009 to December 
2015 (N=322) 
Patient cooled to target temperature of 33.5 °C 
(N=279) 
Patient kept at 33.5 °C for 24 hours (N=279) 
Patient rewarmed to 37.0 °C (N=210) 
Excluded for dying during 
rewarming (N=9) 
Excluded for dying during TTM 
(N=4) 
Excluded for no ECGs prior to 
cooling (N=11) 
Excluded for no ECGs during 
TTM (N=65) 
Adult patients who had a non-traumatic cardiac 
arrest with ECGs prior to cooling, during TTM and 
after rewarming (N=169) 
Excluded for paced rhythm 
(N=7) 
Excluded for no ECGs after 
rewarming (N=32) 
Excluded for no EKGs (N=25) 
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Figure 2: Change in Heart Rate Before, During and After TTM 
 
Histogram results of heart rate changes from before, during and after targeted temperature 
























HR Throughout TTM 
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Figure 3: Change in PR Interval Before, During and After TTM 
 
Histogram results of PR interval changes from before, during and after targeted temperature 






















PR Interval Throughout TTM 
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Figure 4: Change in QRS Interval Before, During and After TTM 
 
Histogram results of QRS interval decreases when during targeted temperature management 























QRS Throughout TTM 
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Figure 5: Change in QTc Before, During and After TTM 
 
Histogram results of QTc interval changes from before, during and after targeted temperature 

























QTc Throughout TTM 
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Patient characteristics (n = 199) 
Age (years) 61.0 ± 16.9 
Male  (%) 125 (62.5%)  
Out-of-hospital Cardiac Arrest (%) 151 (75.9%) 
Body Mass Index (Median, IQR) 29.6 (25, 35.8) 
Witnessed Arrest (%) 73 (66.4%) 
VT/VF (%) 33(30.0%) 
Bradyasystolic (%) 67 (52.8%) 
STEMI (%) 32(16.1%) 
Survived to Discharge (%) 35.7 
Alive at 3 month Follow-up (%) 21.1 
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Table 2: Frequency of Cardiac Rhythms and Conduction Disturbances Before, During and After 
Treatment 
 




  History Before 
Cooling 
New Finding 24 Hours 
Post ROSC 
48 Hours Post 
ROSC 
Atrial Fibrillation 24 3 7 
Atrial Flutter 3 1 1 
Osborn Waves 1 23 4 
AV Nodal Rhythm 7 6 2 
Right Bundle Branch 
Block 
29 2 5 
Left Bundle Branch 
Block 
21 0 0 
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 Before TTM During TTM p-value 
Heart Rate (bpm) 96.1 ± 25.8 69.5 ± 19.1 <0.05 
PR interval (msec) 167.1 ± 34.5 167.5 ± 37.4 0.9 
QRS Duration (msec) 115.7 ± 32.0 108.1 ± 27.9 <0.05 
QTc Interval (msec) 488.0 ± 51.9 527.8 ± 61.0 <0.05 
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 During TTM After TTM  p-value 
Heart Rate (bpm) 69.5 ± 19.1 91.1 ± 18.0 <0.05 
PR interval (msec) 167.5 ± 37.4 159.1 ± 35.3 < 0.05 
QRS Duration (msec) 108.1 ± 27.9 97.5 ± 25.6 <0.05 
QTc Interval (msec) 527.8 ± 61.0 488.7 ± 54.2 <0.05 
